Stay updated with breaking news from Nasdaq mygn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Myriad Genetics (NASDAQ:MYGN – Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.05, Briefing.com reports. The company had revenue of $191.90 million for the quarter, compared to analysts’ expectations of $179.23 million. Myriad Genetics had a […] ....
Myriad Genetics (NASDAQ:MYGN – Get Free Report) had its price objective decreased by equities researchers at JPMorgan Chase & Co. from $17.00 to $14.00 in a report issued on Tuesday, Benzinga reports. The brokerage presently has an “underweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would suggest a potential downside of 21.30% […] ....
Myriad Genetics (NASDAQ:MYGN – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday. Several other analysts also recently issued reports on MYGN. JPMorgan Chase & Co. decreased their target price on Myriad Genetics from $18.00 to $17.00 and […] ....
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have been assigned a consensus rating of “Hold” from the five analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating on the […] ....
StockNews.com began coverage on shares of Myriad Genetics (NASDAQ:MYGN – Free Report) in a report issued on Thursday morning. The brokerage issued a hold rating on the stock. Several other equities research analysts have also issued reports on the company. JPMorgan Chase & Co. dropped their price objective on Myriad Genetics from $18.00 to $17.00 […] ....